Conditions: Schizophrenia
Keywords: Alkermes schizophrenia ALKS 9072 ALKS 9070 aripiprazole lauroxil
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 623
Healthy volunteers: no

Brief summary:
The study will determine the efficacy of ALKS 9072 (also known as aripiprazole lauroxil or ALKS 9070) for the treatment of schizophrenia in subjects experiencing an acute exacerbation.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: ALKS 9072 intervention 2: Placebo
Intervention descriptions: intervention 1: Intramuscular (IM) injection, 441 mg or 882 mg given monthly intervention 2: Placebo for IM injection, given monthly

Protocol document: